切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 169 -172. doi: 10.3877/cma.j.issn.2095-3216.2017.04.007

所属专题: 文献

专家论坛

肾病综合征高凝状态形成机制与中医治疗
魏连波1()   
  1. 1. 510315 南方医科大学深圳医院
  • 收稿日期:2017-05-19 出版日期:2017-08-28
  • 通信作者: 魏连波

Mechanism of hypercoagulability in nephrotic syndrome and traditional Chinese medicine treatment

Lianbo Wei1,()   

  1. 1. Department of Nephrology, Shenzhen Hospital of Southern Medical University, Shenzhen 510315, China
  • Received:2017-05-19 Published:2017-08-28
  • Corresponding author: Lianbo Wei
  • About author:
    Corresponding author: Wei Lianbo, Email:
引用本文:

魏连波. 肾病综合征高凝状态形成机制与中医治疗[J/OL]. 中华肾病研究电子杂志, 2017, 06(04): 169-172.

Lianbo Wei. Mechanism of hypercoagulability in nephrotic syndrome and traditional Chinese medicine treatment[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2017, 06(04): 169-172.

由于内皮细胞的损伤、凝血系统的激活、抗凝血功能的低下、纤溶系统功能减弱、血小板功能亢进、糖皮质激素的使用等,使肾病综合征(NS)患者处于高凝状态,易发生血栓栓塞性疾病。中医认为其基本病机以脾肾亏虚为本,瘀血等证为标为实。中医的辨证论治、辨病与辨证结合等治疗,对其有良好临床疗效。

Patients with nephrotic syndrome (NS) are in a hypercoagulable state, and prone to suffering from thromboembolic diseases due to endothelial cell damage, coagulation system activation, anti-coagulation dysfunction, weakened fibrinolytic system function, platelet hyperfunction, and the use of glucocorticoids. In traditional Chinese medicine (TCM) theory, the basic mechanisms of hypercoagulability in nephrotic syndrome includes spleen and kidney deficiency as the primary, and blood stasis and others as both the secondary and excess. The TCM treatment, based on syndrome differentiation and combination of disease differentiation and syndrome differentiation, may have good clinical efficacy for it.

[1]
Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease [J]. Clin J Am Soc Nephrol, 2012, 7(3): 513-520.
[2]
Malyszko J, Malyszko JS, Mysliwiec M. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome [J]. Blood Coagul Fibrinolysis, 2002, 13(7): 615-621.
[3]
张炯,刘志红.肾病综合征血栓栓塞症的病理生理学基础[J]. 肾脏病与透析肾移植杂志,2010,19(05): 455-459.
[4]
陆美金.肾病综合征凝血机制的研究现状及其进展[J]. 中国实用医药,2014,9(34): 244-245.
[5]
Fukuda T, Tsuji N, Honda Y, et al. Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates [J]. Thromb Haemost, 2011, 106(6): 1062-1068.
[6]
Tkaczyk M, Czupryniak A, Owczarek D, et al. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome [J]. Am J Nephrol, 2008, 28(2): 197-202.
[7]
Hamano K, Iwano M, Akai Y, et al. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis [J]. Am J Kidney Dis, 2002, 39(4): 695-705.
[8]
张莹,夏正坤.儿童原发性肾病综合征并发高凝状态与血栓栓塞的机制[J]. 肾脏病与透析肾移植杂志,2012,21(01): 64-67.
[9]
Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management [J]. Thromb Res, 2006, 118(3): 397-407.
[10]
Tkaczyk M, Baj Z. Surface markers of platelet function in idiopathic nephrotic syndrome in children [J]. Pediatr Nephrol, 2002, 17(8): 673-677.
[11]
Zhang H, Wang Z, Dong L, et al. New insight into the pathogenesis of minimal change nephrotic syndrome: Role of the persistence of respiratory tract virus in immune disorders [J]. Autoimmun Rev, 2016, 15(7): 632-637.
[12]
赵希森,苏丽,王旭贞.肾病综合征高凝状态的中医治疗体会[J]. 现代中西医结合杂志,2002,11(22): 2261.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 易柏成, 李旭光, 王容容, 王新璇. 数字化3D打印导板应用于上前牙钙化根管治疗2例[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 385-390.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[6] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[7] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[8] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[9] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[10] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[11] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[12] 国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[13] 王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[14] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?